Lutetium-177-FAP-75

Lutetium-177 labeled FAP-75 radiopharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lutetium-177-FAP-75, covering 2024-08-14 to 2024-08-14. Get the full timeline:

Most recent: Clinical Trial Update: A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors [Phase 1]